Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
2.690
-0.140 (-4.95%)
May 6, 2025, 3:33 PM EDT - Market open

Aquestive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
26632513549156180
Upgrade
Market Cap Growth
140.67%140.67%176.07%-68.73%-13.14%-3.55%
Upgrade
Enterprise Value
23128415585169229
Upgrade
Last Close Price
2.833.562.020.903.895.35
Upgrade
PS Ratio
4.265.642.671.023.073.92
Upgrade
PB Ratio
-4.40-5.40-1.27-0.41-1.90-3.71
Upgrade
EV/Sales Ratio
4.024.933.061.793.324.99
Upgrade
Debt / Equity Ratio
-0.63-0.63-0.31-0.48-0.69-0.83
Upgrade
Asset Turnover
0.730.730.880.800.810.65
Upgrade
Inventory Turnover
2.792.793.323.954.614.87
Upgrade
Quick Ratio
4.184.181.770.811.831.84
Upgrade
Current Ratio
4.684.682.241.012.152.12
Upgrade
Return on Assets (ROA)
-24.21%-24.21%-16.49%-44.16%-34.71%-37.93%
Upgrade
Return on Capital (ROIC)
------116.06%
Upgrade
Earnings Yield
-16.66%-13.60%-5.83%-111.37%-45.15%-31.01%
Upgrade
FCF Yield
-13.56%-11.07%-5.47%-22.20%-21.69%-25.56%
Upgrade
Buyback Yield / Dilution
-41.58%-41.58%-25.69%-27.99%-13.15%-32.71%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q